Abstract
Five primary prostanoids are synthesized by the cyclooxygenase enzymes, COX-1 and COX-2: the prostaglandins PGE2, PGF2α, PGI2, PGD2 and thromboxane A2. High levels of these signaling molecules have been implicated—in both animal models and human studies—in decreased functional bladder capacity and micturition volume and increased voiding contraction amplitude. Thus, inhibition of prostanoid production or the use of prostanoid receptor antagonists, might be a rational way to treat patients with detrusor muscle overactivity. Similarly, prostanoid receptor agonists, or agents that stimulate their production, might have a function in treating bladder underactivity. Although some promising results have been reported, the adverse effects of nonselective cyclooxygenase inhibitors are a major concern that restricts their use in the treatment of functional bladder disorders. Further preclinical and clinical studies are needed before cyclooxygenase inhibitors, prostanoid receptor agonists and antagonists become worthwhile therapeutic tools in this setting.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boutaud, O. et al. Prostaglandin H2 (PGH2) accelerates formation of amyloid β1–42 oligomers. J. Neurochem. 82, 1003–1006 (2002).
Salomon, R. G., Miller, D. B., Zagorski, M. G. & Coughlin, D. J. Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. J. Am. Chem. Soc. 106, 6049–6060 (1984).
Gilmore, N. J. & Vane, J. R. Hormones released into the circulation when the urinary bladder of the anaesthetized dog is distended. Clin. Sci. 41, 69–83 (1971).
Andersson, K. E. Overactive bladder—pharmacological aspects. Scand. J. Urol. Nephrol. Suppl. 210, 72–81 (2002).
Nile, C. J. & Gillespie, J. I. Interactions between cholinergic and prostaglandin signaling elements in the urothelium: role for muscarinic type 2 receptors. Urology 79, 240.e17–23 (2012).
Kobayter, S., Young, J. S. & Brain, K. L. Prostaglandin E2 induces spontaneous rhythmic activity in mouse urinary bladder independently of efferent nerves. Br. J. Pharmacol. 165, 401–413 (2012).
Khalaf, I. M., Lehoux, J. G., Elshawarby, L. A. & Elhilali, M. M. Release of prostaglandins into the pelvic venous blood of dogs in response to vesical distension and pelvic nerve stimulation. Invest. Urol. 17, 244–247 (1979).
Khalaf, I. M., Ghoneim, M. A. & Elhilali, M. M. The effect of exogenous prostaglandins F2α and E2 and indomethacin on micturition. Br. J. Urol. 53, 21–28 (1981).
Husted, S., Sjögren, C. & Andersson, K. E. Role of prostaglandins in the responses of rabbit detrusor to non-cholinergic, non-adrenergic nerve stimulation and to ATP. Arch. Int. Pharmacodyn. Ther. 246, 84–97 (1980).
Downie, J. W. & Karmazyn, M. Mechanical trauma to bladder epithelium liberates prostanoids which modulate neurotransmission in rabbit detrusor muscle. J. Pharmacol. Exp. Ther. 230, 445–449 (1984).
Abrams, P. H., Sykes, J. A., Rose, A. J. & Rogers, A. F. The synthesis and release of prostaglandins by human urinary bladder muscle in vitro. Invest. Urol. 16, 346–348 (1979).
Kim, J. C., Park, E. Y., Seo, S. I., Park, Y. H. & Hwang, T. K. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J. Urol. 175, 1773–1776 (2006).
Liu, H. T., Tyagi, P., Chancellor, M. B. & Kuo, H. C. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int. 106, 1681–1685 (2010).
Bultitude, M. I., Hills, N. H. & Shuttleworth, K. E. Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br. J. Urol. 48, 631–637 (1976).
Khalaf, I. M., Rioux, F., Quirion, R. & Elhilali, M. M. Intravesical prostaglandin: release and effect of bladder instillation on some micturition parameters. Br. J. Urol. 52, 351–356 (1980).
Klarskov, P. Influence of prostaglandins and ketoprofen on contractile responses of human and pig detrusor and trigone muscles in vitro. Pharmacol. Toxicol. 61, 37–41 (1987).
Poggesi, L. et al. The role of prostaglandins in the maintenance of the tone of the rabbit urinary bladder. Invest. Urol. 17, 454–458 (1980).
Brown, W. W., Zenser, T. V. & Davis, B. B. Prostaglandin E2 production by rabbit urinary bladder. Am. J. Physiol. 239, F452–F458 (1980).
Leslie, C. A., Pavlakis, A. J., Wheeler, J. S. Jr, Siroky, M. B. & Krane, R. J. Release of arachidonate cascade products by the rabbit bladder: neurophysiological significance? J. Urol. 132, 376–379 (1984).
Jeremy, J. Y., Mikhailidis, D. P. & Dandona, P. The rat urinary bladder produces prostacyclin as well as other prostaglandins. Prostaglandins Leukot. Med. 16, 235–248 (1984).
Larsson, C. Production and effects of prostaglandins in the detrusor from homo, cat, rabbit, and rat. Adv. Prostaglandin Thromboxane Res. 8, 1263–1267 (1980).
Reyes, A. A. & Klahr, S. Bladder contributes to eicosanoids excreted in urine. Am. J. Physiol. 259 (5 Pt 2), F859–F861 (1990).
de Jongh, R. et al. The localization of cyclo-oxygenase immuno-reactivity (COX I–IR) to the urothelium and to interstitial cells in the bladder wall. J. Cell. Mol. Med. 13, 3069–3081 (2009).
de Jongh, R. et al. The effects of exogenous prostaglandins and the identification of constitutive cyclooxygenase I and II immunoreactivity in the normal guinea pig bladder. BJU Int. 100, 419–429 (2007).
Park, J. M. et al. Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am. J. Physiol. 273 (4 Pt 2), F538–F544 (1997).
Vane, J. R., Bakhle, Y. S. & Botting, R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38, 97–120 (1998).
Rouzer, C. A. & Marnett, L. J. Cyclooxygenases: structural and functional insights. J. Lipid Res. 50 (Suppl.), S29–S34 (2009).
Lecci, A. et al. Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats. Br. J. Pharmacol. 130, 331–338 (2000).
Birder, L. A. & de Groat, W. C. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat. Clin. Pract. Urol. 4, 46–54 (2007).
Rahnama'i, M. S. et al. Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria. J. Urol. 183, 1241–1247 (2010).
Ikeda, Y. & Kanai, A. Urotheliogenic modulation of intrinsic activity in spinal cord-transected rat bladders: role of mucosal muscarinic receptors. Am. J. Physiol. Renal Physiol. 295, F454–F461 (2008).
Kanai, A. et al. Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonists. Am. J. Physiol. Renal Physiol. 292, F1065–F1072 (2007).
Klausner, A. P. et al. Prostaglandin E2 mediates spontaneous rhythmic contraction in rabbit detrusor muscle. Can. J. Urol. 18, 5608–5614 (2011).
Anderson, G. F. Evidence for a prostaglandin link in the purinergic activation of rabbit bladder smooth muscle. J. Pharmacol. Exp. Ther. 220, 347–352 (1982).
Nile, C. J., de Vente, J. & Gillespie, J. I. Stretch independent regulation of prostaglandin E2 production within the isolated guinea-pig lamina propria. BJU Int. 105, 540–548 (2010).
Maggi, C. A. et al. Evidence for the involvement of arachidonic acid metabolites in spontaneous and drug-induced contractions of rat urinary bladder. J. Pharmacol. Exp. Ther. 230, 500–513 (1984).
Andersson, K. E., Ek, A. & Persson, C. G. Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol. Scand. 100, 165–171 (1977).
Andersson, K. E. & Forman, A. Effects of prostaglandins on the smooth muscle of the urinary tract. Acta Pharmacol. Toxicol. (Copenh.) 43 (Suppl. 2), 90–95 (1978).
Khanna, O. P., Barbieri, E. J. & McMichael, R. Effects of prostaglandins on vesicourethral smooth muscle of rabbit. Therapeutic implications. Urology 12, 674–681 (1978).
Klarskov, P., Gerstenberg, T., Ramirez, D., Christensen, P. & Hald, T. Prostaglandin type E activity dominates in urinary tract smooth muscle in vitro. J. Urol. 129, 1071–1074 (1983).
Maggi, C. A. et al. Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents. Eur. J. Pharmacol. 145, 105–112 (1988).
Ueda, S., Satake, N. & Shibata, S. α1- and α2-adrenoceptors in the smooth muscle of isolated rabbit urinary bladder and urethra. Eur. J. Pharmacol. 103, 249–254 (1984).
Gotoh, M., Hassouna, M. & Elhilali, M. M. The mode of action of prostaglandin E2, F2α and prostacyclin on vesicourethral smooth muscle. J. Urol. 135, 431–437 (1986).
Poli, E., Macaluso, G. & Pozzoli, C. Actions of two novel prostaglandin analogs, SC-29169 and SC-31391, on guinea pig and human isolated urinary bladder. Gen. Pharmacol. 23, 805–809 (1992).
Brugger, N., Kim, N. N., Araldi, G. L., Traish, A. M. & Palmer, S. S. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. J. Sex. Med. 5, 344–356 (2008).
Jeremy, J. Y. et al. Eicosanoid synthesis by human urinary bladder mucosa: pathological implications. Br. J. Urol. 59, 36–39 (1987).
Khera, M., Boone, T. B., Salas, N., Jett, M. F. & Somogyi, G. T. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 99, 442–446 (2007).
Palea, S. et al. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. Br. J. Pharmacol. 124, 865–872 (1998).
Collins, C. et al. Potential for control of detrusor smooth muscle spontaneous rhythmic contraction by cyclooxygenase products released by interstitial cells of Cajal. J. Cell. Mol. Med. 13, 3236–3250 (2009).
Schüssler, B. Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study. Urol. Res. 18, 349–352 (1990).
McCafferty, G. P., Misajet, B. A., Laping, N. J., Edwards, R. M. & Thorneloe, K. S. Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice. Am. J. Physiol. Renal Physiol. 295, F507–F514 (2008).
Ishizuka, O., Mattiasson, A. & Andersson, K. E. Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? J. Urol. 153, 2034–2038 (1995).
Park, J. M. et al. Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch. Am. J. Physiol. 276, F129–F136 (1999).
Hu, V. Y. et al. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R574–R585 (2003).
Kim, J. C. et al. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int. J. Urol. 12, 875–880 (2005).
Alexander, S. P., Mathie, A. & Peters, J. A. Guide to Receptors and Channels (GRAC), 3rd edition. Br. J. Pharmacol. 153 (Suppl. 2), S1–S209 (2008).
Negishi, M., Sugimoto, Y. & Ichikawa, A. Prostaglandin E receptors. J. Lipid Mediat. Cell Signal. 12, 379–391 (1995).
Coleman, R. A., Smith, W. L. & Narumiya, S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205–229 (1994).
Ikeda, M., Kawatani, M., Maruyama, T. & Ishihama, H. Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats. Biomed. Res. 27, 49–54 (2006).
Naganawa, A. et al. Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists. Bioorg. Med. Chem. 14, 6628–6639 (2006).
Schröder, A., Newgreen, D. & Andersson, K. E. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J. Urol. 172, 1166–1170 (2004).
Lee, T., Hedlund, P., Newgreen, D. & Andersson, K. E. Urodynamic effects of a novel EP1 receptor antagonist in normal rats and rats with bladder outlet obstruction. J. Urol. 177, 1562–1567 (2007).
Rahnama'i, M. S. et al. The relationship between prostaglandin E receptor 1 and cyclooxygenase I expression in guinea pig bladder interstitial cells: proposition of a signal propagation system. J. Urol. 185, 315–322 (2011).
Jugus, M. J. et al. Dual modulation of urinary bladder activity and urine flow by prostanoid EP receptors in the conscious rat. Br. J. Pharmacol. 158, 372–381 (2009).
Chuang, Y. C. et al. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur. Urol. 56, 159–166 (2009).
Beppu, M. et al. Bladder outlet obstruction induced expression of prostaglandin E2 receptor subtype EP4 in the rat bladder: a possible counteractive mechanism against detrusor overactivity. J. Urol. 186, 2463–2469 (2011).
Chuang, Y. C. et al. Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats. BJU Int. 106, 1782–1787 (2010).
Masunaga, K. et al. Prostaglandin E2 release from isolated bladder strips in rats with spinal cord injury. Int. J. Urol. 13, 271–276 (2006).
Andersson, K. E. et al. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr. Opin. Urol. 19, 380–394 (2009).
Morikawa, K. et al. Detrusor hyperreflexia induced by intravesical instillation of xylene in conscious rats. Jpn J. Pharmacol. 52, 587–595 (1990).
Kibar, Y. et al. The effect of intravesical acetylsalicylic acid instillation on tissue prostaglandin levels after partial bladder outlet obstruction in rabbits. Neurourol. Urodyn. 30, 1646–1651 (2011).
Angelico, P. et al. Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes. BJU Int. 97, 837–846 (2006).
Cardozo, L. D. & Stanton, S. L. A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J. Urol. 123, 399–401 (1980).
Cardozo, L. D., Stanton, S. L., Robinson, H. & Hole, D. Evaluation of flurbiprofen in detrusor instability. Br. Med. J. 280, 281–282 (1980).
Sprem, M., Milicic´, D., Oreskovic´, S., Ljubojevic´, N. & Kalafatic´, D. Intravesically administered ketoprofen in treatment of detrusor instability: cross-over study. Croat. Med. J. 41, 423–427 (2000).
Zemmel, M. H. The role of COX-2 inhibitors in the perioperative setting: efficacy and safety—a systematic review. AANA J. 74, 49–60 (2006).
Bergman, A., Mushkat, Y., Gordon, D. & David, M. P. Prostaglandin for enhancing bladder function after vaginal surgery. Does it work? J. Reprod. Med. 37, 320–322 (1992).
Delaere, K. P., Thomas, C. M., Moonen, W. A. & Debruyne, F. M. The value of intravesical prostaglandin E2 and F2α in women with abnormalities of bladder emptying. Br. J. Urol. 53, 306–309 (1981).
Hindley, R. G., Brierly, R. D. & Thomas, P. J. Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int. 93, 89–92 (2004).
Buckley, B. S. & Lapitan, M. C. Drugs for treatment of urinary retention after surgery in adults. Cochrane Database Syst. Rev. CD008023 (2010).
Bergman, A., Mushket, Y., Gordon, D. & David, M. P. Prostaglandin prophylaxis and bladder function after vaginal hysterectomy: a prospective randomised study. Br. J. Obstet. Gynaecol. 100, 69–72 (1993).
Koonings, P. P., Bergman, A. & Ballard, C. A. Prostaglandins for enhancing detrusor function after surgery for stress incontinence in women. J. Reprod. Med. 35, 1–5 (1990).
Andersson, K. E. & Arner, A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84, 935–986 (2004).
Maggi, C. A. Prostanoids as local modulators of reflex micturition. Pharmacol. Res. 25, 13–20 (1992).
Yokoyama, O. et al. Antimuscarinics suppress adenosine triphosphate and prostaglandin E2 release from urothelium with potential improvement in detrusor overactivity in rats with cerebral infarction. J. Urol. 185, 2392–2397 (2011).
Downie, J. W. & Larsson, C. Prostaglandin involvement in contractions evoked in rabbit detrusor by field stimulation and by adenosine 5'-triphosphate. Can. J. Physiol. Pharmacol. 59, 253–260 (1981).
Tanaka, I. et al. Modulation of stretch evoked adenosine triphosphate release from bladder epithelium by prostaglandin E2 . J. Urol. 185, 341–346 (2011).
Birder, L. Role of the urothelium in bladder function. Scand. J. Urol. Nephrol Suppl. 215, 48–53 (2004).
van Koeveringe, G. A., Vahabi, B., Andersson, K. E., Kirschner-Herrmans, R. & Oelke, M. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol. Urodyn. 30, 723–728 (2011).
Wilbraham, D., Masuda, T., Deacon, S., Kuwayama, T. & Vincent, S. Safety, tolerability, and pharmacokinetic of multiple ascending doses of the EP-1 receptor antagonist ONO-8539, a potential new and novel therapy to overactive bladder in healthy young and elderly subjects [abstract]. Eur. Urol. 9 (Suppl.), 250 (2010).
Acknowledgements
This study was supported, in part, by an unconditional personal research grant (Mozaïek) to M. S. Rahnama'i by The Netherlands Organisation for Scientific Research (NWO). We are grateful to Dr Jan de Vente for his help with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
M. S. Rahnama'i researched the data for the article and wrote the manuscript. G. A. van Koeveringe contributed to the discussions of its content. All authors reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
G. A. van Koeveringe declares that he has been on the advisory boards for Allergan and Astellas Pharma.
Rights and permissions
About this article
Cite this article
Rahnama'i, M., van Kerrebroeck, P., de Wachter, S. et al. The role of prostanoids in urinary bladder physiology. Nat Rev Urol 9, 283–290 (2012). https://doi.org/10.1038/nrurol.2012.33
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2012.33
This article is cited by
-
The five primary prostaglandins stimulate contractions and phasic activity of the urinary bladder urothelium, lamina propria and detrusor
BMC Urology (2020)
-
Hypoactivity of rat detrusor muscle in a model of cystitis: exacerbation by non-selective COX inhibitors and amelioration by a selective DP1 receptor antagonist
Naunyn-Schmiedeberg's Archives of Pharmacology (2019)
-
Combination treatment of nocturnal enuresis with desmopressin and indomethacin
Pediatric Nephrology (2017)
-
Updates of underactive bladder: a review of the recent literature
International Urology and Nephrology (2016)
-
Pathophysiology and animal modeling of underactive bladder
International Urology and Nephrology (2014)